Healthy Skepticism Library item: 12188
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
Arnold M.
Novartis targets oncologists with blog
Medical Marketing and Media 2007 Dec 1
http://www.mmm-online.com/Novartis-targets-oncologists-with-blog/article/99551/
Abstract:
Novartis is experimenting with blogging for physicians with melanomaperspectives.com.
Executed by Compass Healthcare Communications, it went live in August with a panel of five knowledge and opinion leader contributors.
Though the site is unbranded, Novartis hopes to educate referring and community oncologists about the benefits of interleukin-2 therapies like the company’s Proleukin, for metastatic melanoma and metastatic kidney cancer. A late-stage treatment, Proleukin suffers from a lack of awareness regarding the timing and usage of immunotherapy versus chemotherapy.
As the site does not have comments, Novartis doesn’t have to worry about the thorny issue of adverse events reporting. All content is reviewed by the company for medical, regulatory and legal correctness before posting. It will be supported by search engine optimization, details and banner ads.
